Are you Dr. Pullarkat?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 83 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Division of Leukemia
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-389-3061- Is this information wrong?
Summary
- Dr. Vinod Pullarkat, MD is an oncologist in Duarte, California. He is currently licensed to practice medicine in California and Utah. He is affiliated with City of Hope Comprehensive Cancer Center, Keck Hospital of USC, and USC Norris Comprehensive Cancer Center.
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1998 - 2000- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 1997 - 1998
New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 1994 - 1997
Medical College and Hospital KolkataClass of 1992
Certifications & Licensure
CA State Medical License 1997 - 2025
UT State Medical License 1996 - 1998- American Board of Internal Medicine Hematology
Clinical Trials
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Start of enrollment: 2010 Mar 22
- Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy Start of enrollment: 2011 Jul 01
- Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. Start of enrollment: 2014 Sep 11
Publications & Presentations
PubMed
- 1 citationsLong-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.Keith W Pratz, Brian A Jonas, Vinod Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Récher, Walter Fiedler, Kazuhito Yamamoto, Jianxiang W...> ;American Journal of Hematology. 2024 Apr 1
- Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer.Al Malki, M. M., Jianying Zhang, Jose Tinajero, Hoda Pourhassan, Vinod Pullarkat, Vaibhav Agrawal, Paul Koller, Ahmed Aribi, Amandeep Salhotra, Karamjeet Sandhu, Haris...> ;British Journal of Haematology. 2024 Mar 31
- A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and ...Al Malki, M. M., Ryotaro Nakamura, Corinna La Rosa, Dongyun Yang, Joshua A Hill, Armin Rashidi, Hannah Choe, Qiao Zhou, Chetan Raj Lingaraju, Teodora Kaltcheva, Jeffre...> ;Haematologica. 2024 Feb 8
- Join now to see all
Authored Content
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaAugust 2020
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaAugust 2020
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaAugust 2020
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaAugust 2020
- Join now to see all
Press Mentions
Improving Outcomes in Older Patients with Newly Diagnosed ALLMay 9th, 2019
Excess Iron in MDSOctober 7th, 2016
FDA Approves Oral Factor B Inhibitor for Paroxysmal Nocturnal HemoglobinuriaDecember 8th, 2023- Join now to see all
Hospital Affiliations
Keck Hospital of USCLos Angeles, California
Los Angeles General Medical CenterLos Angeles, California
USC Norris Comprehensive Cancer CenterLos Angeles, California
City of Hope Comprehensive Cancer CenterDuarte, California
